BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16127675)

  • 21. The impact of pharmacotherapy policy: a case study.
    Tamblyn R
    Can J Clin Pharmacol; 2001; 8 Suppl A():39A-44A. PubMed ID: 11586378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Price elasticity of expenditure across health care services.
    Duarte F
    J Health Econ; 2012 Dec; 31(6):824-41. PubMed ID: 22975470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlling prescription drug expenditures: a report of success.
    Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
    Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay.
    Groves S; Cohen D; Alam MF; Dunstan FD; Routledge PA; Hughes DA; Myles S
    Int J Pharm Pract; 2010 Dec; 18(6):332-40. PubMed ID: 21054593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a large increase in cigarette tax on cigarette consumption: an empirical analysis of cross-sectional survey data.
    Lee JM
    Public Health; 2008 Oct; 122(10):1061-7. PubMed ID: 18602655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the demand for prescription drugs: heterogeneity in price responses.
    Skipper N
    Health Econ; 2013 Jul; 22(7):857-69. PubMed ID: 22899231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Income related inequality in prescription drugs in Denmark.
    Gundgaard J
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):307-17. PubMed ID: 15508133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
    Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
    Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How price responsive is the demand for specialty care?
    Maciejewski ML; Liu CF; Kavee AL; Olsen MK
    Health Econ; 2012 Aug; 21(8):902-12. PubMed ID: 21755570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. You save money when you buy in bulk: does volume-based pricing cause people to buy more beer?
    Bray JW; Loomis BR; Engelen M
    Health Econ; 2009 May; 18(5):607-18. PubMed ID: 18770524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.
    Hansen RA; Shaheen NJ; Schommer JC
    Clin Ther; 2005 Sep; 27(9):1478-87. PubMed ID: 16291421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of drug prescription monitoring systems in the extra-hospital environment.
    Lucioni C; Rossi F
    Ann Ist Super Sanita; 1991; 27(2):225-33. PubMed ID: 1755575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health insurance take-up by the near-elderly.
    Buchmueller TC; Ohri S
    Health Serv Res; 2006 Dec; 41(6):2054-73. PubMed ID: 17116109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social Security cost-of-living adjustments and the Consumer Price Index.
    Burdick C; Fisher L
    Soc Secur Bull; 2007; 67(3):73-88. PubMed ID: 18605219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Out-of-pocket pharmacy expenditures for veterans under medicare part D.
    Rupper RW; Bair BD; Sauer BC; Nebeker JR; Shinogle J; Samore M
    Med Care; 2007 Oct; 45(10 Supl 2):S77-80. PubMed ID: 17909387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cigarette demand: a meta-analysis of elasticities.
    Gallet CA; List JA
    Health Econ; 2003 Oct; 12(10):821-35. PubMed ID: 14508867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of patient cost-sharing on low-income populations: evidence from Massachusetts.
    Chandra A; Gruber J; McKnight R
    J Health Econ; 2014 Jan; 33():57-66. PubMed ID: 24287175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.